GlassScriptPhysician profile
Najia Lawrence
NPI 1790841096
$2,622.91
in general payments reported to CMS, 2019-2025
36 companies · $310 in 2025
The $310 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $701 · 2020: $143 · 2021: $392 · 2022: $347 · 2023: $402 · 2024: $329 · 2025: $310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $941 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $940.85 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $497.51 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $362.07 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $196.10 | 2019-2025 | |
| Nuwellis, INC. | $193.33 | 2019 | |
| Mayne Pharma Commercial LLC | $149.27 | 2023-2025 | |
| Organon LLC | $135.43 | 2021-2025 | Nexplanon, Jada System |
| Pfizer INC. | $122.03 | 2020-2024 | |
| Coopersurgical, INC. | $84.12 | 2019-2025 | Paragard T 380a |
| Optumhealth Care Solutions, LLC | $74.95 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Evofem Biosciences, INC. | $65.45 | 2021-2025 | Phexxi, Solosec, Phexx |
| Takeda Pharmaceuticals U.S.A., INC. | $65.21 | 2021 | |
| Myovant Sciences INC. | $63.77 | 2021-2022 | |
| Amgen INC. | $58.52 | 2019 | |
| Therapeuticsmd, INC. | $50.82 | 2020-2021 | |
| Ethicon US, LLC | $50.33 | 2021-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $48.39 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Merck Sharp & Dohme LLC | $44.39 | 2019-2021 | |
| Daiichi Sankyo INC. | $39.82 | 2019 | |
| Duchesnay USA Incorporated | $30.69 | 2019 | |
| Biogen, INC. | $29.80 | 2024 | Zurzuvae |
| Avion Pharmaceuticals | $24.61 | 2021-2022 | |
| Exeltis, USA INC. | $20.28 | 2023 | Slynd |
| Baxter Healthcare | $19.67 | 2023 | Tisseel |
| Axonics, INC. | $18.62 | 2023 | Bulkamid, Axonics |
| Lupin INC. | $18.34 | 2019 | |
| Hologic Sales and Service, LLC | $17.23 | 2021 | |
| Eisai INC. | $16.86 | 2020 | |
| Medtronic, INC. | $16.35 | 2024 | Interstim |
| Sumitomo Pharma America, INC. | $15.17 | 2024 | Myfembree |
| Vertical Pharmaceuticals, LLC | $14.34 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.19 | 2019 | |
| Shield Therapeutics INC | $13.86 | 2023 | Accrufer |
| Olympus America INC. | $13.18 | 2023 | Olympus |
| Roche Diagnostics Corporation | $12.82 | 2019 | |
| Meditrina | $12.81 | 2023 | |
| Novo Nordisk INC | $12.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Najia Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.